The Punch Newspapers on MSN15h
Advocating increased funding for sickle cell research: A call to actionSickle cell disease is a severe, inherited blood disorder that primarily affects people of African, Mediterranean, Middle ...
What does Pope Francis having "double pneumonia" mean? What should you look for in the elderly? How can you avoid getting ...
IFLScience on MSN2d
The Pope Has Double Pneumonia – Here’s What That MeansPneumonia is an infection of the lungs that can be caused most commonly by bacteria or viruses, such as Streptococcus ...
Pope Francis has been hospitalized at Gemelli since Friday, February 14. The latest medical bulletin confirms bilateral ...
The patients selected for artificial ventilation had not responded to the initial therapy, were cyanotic ... the findings in cystic fibrosis of the pancreas, but none of our patients had positive ...
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
IFLScience on MSN1d
Inhalable Cystic Fibrosis Gene Therapy 24 Years In The Making Enters Clinical TrialsA new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.
Once-daily vanzacaftor-tezacaftor-deutivacaftor was safe and well-tolerated in children with cystic fibrosis, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback